BlackRock Investment Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-74,379
| Closed | -$7.25M | – | 4271 |
|
|
2015
Q1 | $7.25M | Buy |
74,379
+16,257
| +28% | +$1.59M | 0.01% | 1140 |
|
|
2014
Q4 | $5.39M | Sell |
58,122
-233
| -0.4% | -$21.6K | 0.01% | 1308 |
|
|
2014
Q3 | $4.01M | Sell |
58,355
-86
| -0.1% | -$5.92K | 0.01% | 1495 |
|
|
2014
Q2 | $6.13M | Buy |
58,441
+1,492
| +3% | +$156K | 0.01% | 1254 |
|
|
2014
Q1 | $4.73M | Buy |
56,949
+4,133
| +8% | +$343K | 0.01% | 1400 |
|
|
2013
Q4 | $3.42M | Buy |
52,816
+4,506
| +9% | +$292K | 0.01% | 1614 |
|
|
2013
Q3 | $3.06M | Buy |
48,310
+3,357
| +7% | +$213K | 0.01% | 1626 |
|
|
2013
Q2 | $1.89M | Buy |
+44,953
| New | +$1.89M | ﹤0.01% | 1893 |
|